The AMBER Study, as of August 2019 has reached its recruitment goal! We are now focused on finishing the follow-up assessments, so are no longer enrolling new participants in the study. Thank you for your interest, we appreciate your dedication to helping further research.
|
Before you decide to participate, it is important for you to understand the purpose of the AMBER Study and what is involved. Please take the time to read your information package carefully, and discuss it with others if you wish. Your participation is voluntary and your decision to participate will not affect your medical care in any way.
Who Can Participate?We are looking for women who are age 18 or older and have recently been diagnosed with Stage I-IIIc breast cancer.
|
Edmonton AMBER Study testers, Katy (L) and Steph (R) with our 1001st participant.
|
How Do I Join?
We plan to recruit 1500 women into the AMBER study over a period of 5 years. Recruitment will be done from both Calgary and Edmonton.
In Calgary, recruitment will occur through a variety of different mechanisms. Principally, participants will be recruited through their involvement with the Alberta Cancer Research Biorepository (ACRB) and their willingness to be contacted for additional research. In addition, participants may join the study by contacting the Calgary study coordinator at 403-698-8067.
In Edmonton, recruitment will occur at the Breast Cancer Clinic in the Cross Cancer Institute where potential participants will be approached directly by AMBER study staff. Alternatively, participants may join the study by contacting the Edmonton study coordinator at 780-492-8274.
In Calgary, recruitment will occur through a variety of different mechanisms. Principally, participants will be recruited through their involvement with the Alberta Cancer Research Biorepository (ACRB) and their willingness to be contacted for additional research. In addition, participants may join the study by contacting the Calgary study coordinator at 403-698-8067.
In Edmonton, recruitment will occur at the Breast Cancer Clinic in the Cross Cancer Institute where potential participants will be approached directly by AMBER study staff. Alternatively, participants may join the study by contacting the Edmonton study coordinator at 780-492-8274.
